These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34054834)

  • 1. A 10-Day-Old Murine Model of Coxsackievirus A6 Infection for the Evaluation of Vaccines and Antiviral Drugs.
    Jiang Z; Zhang Y; Lin H; Cheng Q; Lu X; Liu W; Zhou R; Zhong B; Tian X
    Front Immunol; 2021; 12():665197. PubMed ID: 34054834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
    Zhang Z; Dong Z; Wei Q; Carr MJ; Li J; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 May; 91(9):. PubMed ID: 28250116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice.
    Caine EA; Fuchs J; Das SC; Partidos CD; Osorio JE
    Viruses; 2015 Nov; 7(11):5919-32. PubMed ID: 26593938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
    Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
    Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A neonatal murine model of coxsackievirus A4 infection for evaluation of vaccines and antiviral drugs.
    Zhang Z; Zhang X; Carr MJ; Zhou H; Li J; Liu S; Liu T; Xing W; Shi W
    Emerg Microbes Infect; 2019; 8(1):1445-1455. PubMed ID: 31595827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model.
    Qian SS; Wei ZN; Jin WP; Wu J; Zhou YP; Meng SL; Guo J; Wang ZJ; Shen S
    Emerg Microbes Infect; 2021 Dec; 10(1):763-773. PubMed ID: 33739899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model.
    Jin WP; Lu J; Zhang XY; Wu J; Wei ZN; Mai JY; Qian SS; Yu YT; Meng SL; Wang ZJ; Shen S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice.
    Zhang Z; Dong Z; Wang Q; Carr MJ; Li J; Liu T; Li D; Shi W
    Vaccine; 2018 Nov; 36(46):7095-7104. PubMed ID: 30316529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease.
    Lim H; In HJ; Lee JA; Sik Yoo J; Lee SW; Chung GT; Choi YK; Chung JK; Cho SJ; Lee JW
    Vaccine; 2018 Jun; 36(24):3445-3452. PubMed ID: 29739716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.
    Zhang Z; Dong Z; Li J; Carr MJ; Zhuang D; Wang J; Zhang Y; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
    Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
    Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse-adapted CVA6 strain exhibits neurotropism and triggers systemic manifestations in a novel murine model.
    Li D; Sun T; Tao L; Ji W; Zhu P; Liang R; Zhang Y; Chen S; Yang H; Jin Y; Duan G
    Emerg Microbes Infect; 2022 Dec; 11(1):2248-2263. PubMed ID: 36036059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation characteristics of coxsackievirus A10 in mice and immune protection ability of experimental inactivated vaccine.
    Gao W; Yue L; Yang T; Shen D; Li H; Song X; Xie T; He X; Xie Z
    Biomed Pharmacother; 2021 Nov; 143():112212. PubMed ID: 34649345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coxsackievirus A6 Infection Causes Neurogenic Pathogenesis in a Neonatal Murine Model.
    Sun Q; Li J; Wang R; Sun T; Zong Y; Wang C; Liu Y; Li X; Song Y; Zhang Y
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
    Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
    Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.
    Fang CY; Liu CC
    Expert Rev Vaccines; 2018 Sep; 17(9):819-831. PubMed ID: 30095317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment.
    Chen FH; Liu X; Fang HL; Nan N; Li Z; Ning NZ; Luo DY; Li T; Wang H
    Front Immunol; 2019; 10():2564. PubMed ID: 31787970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A neonatal mouse model for the evaluation of antibodies and vaccines against coxsackievirus A6.
    Yang L; Mao Q; Li S; Gao F; Zhao H; Liu Y; Wan J; Ye X; Xia N; Cheng T; Liang Z
    Antiviral Res; 2016 Oct; 134():50-57. PubMed ID: 27582066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease.
    Tsou YL; Lin YW; Shao HY; Yu SL; Wu SR; Lin HY; Liu CC; Huang C; Chong P; Chow YH
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003692. PubMed ID: 25855976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.